HCC podcast series part 1: The use of IO in unresectable HCC

November 21, 2024 00:23:21
HCC podcast series part 1: The use of IO in unresectable HCC
COR2ED - Oncology Medical Conversation
HCC podcast series part 1: The use of IO in unresectable HCC

Nov 21 2024 | 00:23:21

/

Show Notes

In the first of this 4-part podcast series on HCC, Dr Rachna Shroff and Oncology Brothers Drs Rohit and Rahul Gosain explore the use of IO (immunotherapy) in unresectable HCC (uHCC) and take a deep dive into the different treatment options first-line focusing on IO and IO based combinations. Topics include: 

 

 

Key clinical takeaways:

 

 

Follow us on social media: 

LinkedIn: https://www.linkedin.com/company/hcc-connect  

X: https://x.com/hccconnectinfo  

 

This content is intended for healthcare professionals only.  

The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution. AstraZeneca has provided a sponsorship grant towards this independent programme. 

 

This podcast is developed by cor2ed.com 

Published on November 2024 

 

Subscribe to this channel to stay up to date with new Independent Education programmes as they’re released. 

Other Episodes

Episode

April 25, 2024 00:27:48
Episode Cover

Cáncer de pulmón: dificultades en la fase preanalítica y pruebas de biomarcadores

¿Cuáles son los desafíos frecuentes en la fase preanalítica del cáncer de pulmón, y cómo podemos superarlos? ¿Por qué es importante identificar las alteraciones...

Listen

Episode

February 23, 2024 00:32:21
Episode Cover

Ovarian cancer: Pre-analytical phase challenges and biomarker testing

What are the common pre-analytical phase challenges in ovarian cancer, and how can we overcome them? Why is it important to identify genetic alterations?  ...

Listen

Episode

September 11, 2024 00:22:51
Episode Cover

Neuroendocrine tumours (NETs) – Shared decision-making. Part 2: Individualising treatment decisions

In this second episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins...

Listen